Want to join the conversation?
$HRS 4Q15 PR: Initial guidance for fiscal 2016 for GAAP net income is a range of $5.25-5.45 per diluted share and for non-GAAP net income, excluding integration and other acquisition-related charges, is a range of $5.60-5.80 per diluted share. Initial revenue guidance for fiscal 2016 is a range of $7.67-7.83Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?